BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15173493)

  • 1. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma.
    Bacharier LB; Raissy HH; Wilson L; McWilliams B; Strunk RC; Kelly HW
    Pediatrics; 2004 Jun; 113(6):1693-9. PubMed ID: 15173493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
    Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
    J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hypothalamic-pituitary-adrenal axis suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid.
    Ozbek OY; Turktas I; Bakirtas A; Bideci A
    J Pediatr Endocrinol Metab; 2006 Aug; 19(8):1015-23. PubMed ID: 16995587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hypothalamic-pituitary-adrenal axis (HPA) suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid (JPEM 2006; 19: 1015-1023).
    Priftis KN; Papadimitriou A; Anthracopoulos MB; Fretzayas A; Nicolaidou P
    J Pediatr Endocrinol Metab; 2007 Feb; 20(2):261; author reply 261-2. PubMed ID: 17396445
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
    Clark DJ; Lipworth BJ
    Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids.
    Nelson HS; Stricker W; Casale TB; Raff H; Fourré JA; Aron DC; Newman KB
    J Clin Pharmacol; 2002 Mar; 42(3):319-26. PubMed ID: 11865969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma.
    Irani AM; Cruz-Rivera M; Fitzpatrick S; Hoag J; Smith JA
    Ann Allergy Asthma Immunol; 2002 Mar; 88(3):306-12. PubMed ID: 11926625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
    Kosoglou T; Cutler DL; Staudinger H; Herron JM
    Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
    Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
    Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide.
    Volovitz B; Amir J; Malik H; Kauschansky A; Varsano I
    N Engl J Med; 1993 Dec; 329(23):1703-8. PubMed ID: 8232459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary cortisol monitoring: determination of reference values in healthy children and application in asthmatic children.
    Nagakura T; Tanaka T; Arita M; Nishikawa K; Shigeta M; Wada N; Matsumoto T; Hiraba K; Fukuda N
    Allergy Asthma Proc; 2012; 33(4):362-9. PubMed ID: 22856637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it time to reduce our phobia of inhaled corticosteroids?
    Bahna SL
    Pediatrics; 2004 Jun; 113(6):1813-4. PubMed ID: 15173513
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis.
    Kirwan JR; Hickey SH; Hällgren R; Mielants H; Björck E; Persson T; Wollheim FA
    Arthritis Rheum; 2006 May; 54(5):1415-21. PubMed ID: 16645969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner.
    Grebe SK; Feek CM; Durham JA; Kljakovic M; Cooke RR
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):297-304. PubMed ID: 9373450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hypothalamic-pituitary-adrenal axis function with neuropsychological performance in children with mild/moderate asthma.
    Annett RD; Stansbury K; Kelly HW; Strunk RC
    Child Neuropsychol; 2005 Aug; 11(4):333-48. PubMed ID: 16051562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
    Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use.
    Cavkaytar O; Vuralli D; Arik Yilmaz E; Buyuktiryaki B; Soyer O; Sahiner UM; Kandemir N; Sekerel BE
    Eur J Pediatr; 2015 Nov; 174(11):1421-31. PubMed ID: 26255048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations.
    Brannan MD; Herron JM; Reidenberg P; Affrime MB
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):39-44. PubMed ID: 9475565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma.
    Scott MB; Skoner DP
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):200-9. PubMed ID: 10518847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.